Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

The futures traded slightly higher Thursday morning as the markets digested yesterday's upside move. Positive talk on trade and some more benign inflation data were seen as the key reasons ...
Read Full Story »

Why Arena Pharma Is Winning Big With Its New Collaboration

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics Corp. (NASDAQ: UTHR). The goal of this collaboration ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Box, Corning, GrubHub, Hyatt, Quality Systems, Zillow and More

The futures traded slightly higher Thursday morning as investors digested Wednesday’s huge rally, which basically rode on the back of the political situation in Italy cooling off some and Italian ...
Read Full Story »

Arena Pharmaceuticals Wins Big in Midstage Trial

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) watched its shares climb early on Tuesday after the firm announced positive midstage results from its OASIS trial for etrasimod. The Phase 2 topline results ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, BHP Billiton, Dominion, JB Hunt, KLA-Tencor, Micron, Nucor, Oracle, Roku, US Steel and More

Stocks took a hit lower on Monday, but the major indices were looking slightly positive on Tuesday. The bull market is now over nine years old, and investors are still ...
Read Full Story »

Even More Biopharma Catalysts Coming Through the End of March

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Get ready for more mergers and acquisitions in biotech and in emerging pharmaceuticals in 2018. This theme is believed by many investors, and now Credit Suisse is touting that tax ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BofA, Honeywell, IBM, Lululemon, Oracle, United Tech, Wells Fargo and Many More

Stocks did not deviate from hitting all-time highs on the first trading day of the year, and the second trading day of the year is looking positive as well. The ...
Read Full Story »

Did You Just Miss the Launch of the US-Listed Marijuana ETF?

The first trading session after Christmas is almost always a quiet one, and the market is likely to remain quiet until after the start of 2018. The news flow from companies ...
Read Full Story »

Why Arena Pharmaceuticals Is Knocking It Out of the Park

Shares of Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension (PAH). ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

Stocks were indicated to open marginally lower on Tuesday, with no real pull from major news one way or the other. The bull market is now well over eight years ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Enterprise Products, GrubHub, Mattel, Ryanair, Splunk and Many More

Stocks were indicated to open lower on Thursday after the markets hit new highs again on Wednesday, a day after the Federal Reserve hiked rates and announced a sooner than ...
Read Full Story »

Huge Transport Trade Highlights Insider Buying: CSX, GE, Mattel, IFF and More

With first-quarter earnings winding down, but still in the process, the windows for insiders remain closed for the most part, so we had another week of lower volumes. However, with ...
Read Full Story »

Valeant, Arena Pharmaceuticals in Tuesday’s 52-Week Low Club

April 18, 2017: Here are four stocks trading with relatively heavy volume among 85 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw its shares drop sharply on Tuesday after the company announced a secondary offering. Arena plans to offer 60 million shares of its common stock ...
Read Full Story »